Scripta Therapeutics

transcription factors, AI/ML, patient-derived models

modulatingsmall molecule

scriptatherapeutics.com·Oxford, United Kingdom·$12M total funding

Plate C · C-DB8N

Projects

exploratory

platform · high

Discover disease-modifying therapeutics by modulating transcription factor activity to restore health.

Genome-wide transcription factor mapping, AI/ML models, molecule and target prediction, and validation in patient-derived models.

Company website describes the platform and its validation approach; no specific clinical or asset milestone is disclosed.

preclinical

drug program · medium

Develop disease-modifying therapeutics for neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and ALS.

Use transcription factor modulation discovery methods, AI/ML-driven molecule and target prediction, and patient-derived disease models.

First therapeutic focus disclosed as neurodegenerative diseases; no named candidate, target, or clinical stage disclosed.

Loading section...

0-100 chain-logic scale · 15 dimensions · scored on public evidence